Edvardsenotto0012

Compared to whites, blacks have higher colorectal cancer incidence and mortality rates and are at greater risk for early-onset disease. The reasons for this racial disparity are poorly understood, but one contributing factor could be differences in access to high-quality screening and medical care.

The present study was carried out to assess whether a racial difference in prevalence of large bowel polyps persists within a poor and uninsured population (n = 233, 124 blacks, 91 whites, 18 other) undergoing screening colonoscopy.

Eligible patients were uninsured, asymptomatic, had no personal history of colorectal neoplasia, and were between the ages 45-64 years (blacks) or 50-64 years (whites, other). We examined the prevalence of any adenoma (conventional, serrated) and then difference in adenoma/polyp type by race and age categories.

Prevalence for ≥1 adenoma was 37 % (95 % CI 31-43 %) for all races combined and 36 % in blacks <50 years, 38 % in blacks ≥50 years, and 35 % in whites. When stratified by race, blacks had a higher prevalence of large conventional proximal neoplasia (8 %) compared to whites (2 %) (p value = 0.06) but a lower prevalence of any serrated-like (blacks 18 %, whites 32 %; p value = 0.02) and sessile serrated adenomas/polyps (blacks 2 %, whites 8 % Chi-square p value; p = 0.05).

Within this uninsured population, the overall prevalence of adenomas was high and nearly equal by race, but the racial differences observed between serrated and conventional polyp types emphasize the importance of taking polyp type into account in future research on this topic.

Within this uninsured population, the overall prevalence of adenomas was high and nearly equal by race, but the racial differences observed between serrated and conventional polyp types emphasize the importance of taking polyp type into account in future research on this topic.

Budesonide foam, a rectally administered, second-generation corticosteroid with extensive hepatic first-pass metabolism, is efficacious for the treatment of mild-to-moderate ulcerative proctitis and ulcerative proctosigmoiditis.

The aim of this study was to comprehensively assess the safety and pharmacokinetic profile of budesonide foam.

Data from five phase III studies were pooled to further evaluate safety, including an open-label study (once-daily treatment for 8 weeks), an active-comparator study (once-daily treatment for 4 weeks), and two placebo-controlled studies and an open-label extension study (twice-daily treatment for 2 weeks, then once daily for 4 weeks). Data from the placebo-controlled studies and two phase I studies (i.e., patients with mild-to-moderate ulcerative colitis and healthy volunteers) were pooled to evaluate the pharmacokinetics of budesonide foam.

A similar percentage of patients reported adverse events in the budesonide foam and placebo groups, with the majority of adverse events being mild or moderate in intensity (93.3 vs 96.0%, respectively). Adverse events occurred in 41.4 and 36.3% of patients receiving budesonide foam and placebo, respectively. Mean morning cortisol concentrations remained within the normal range for up to 8 weeks of treatment; there were no clinically relevant effects of budesonide foam on the hypothalamic-pituitary-adrenal axis. Population pharmacokinetic analysis demonstrated low systemic exposure after budesonide foam administration.

This integrated analysis demonstrated that budesonide foam for the induction of remission of distal ulcerative colitis is safe overall, with no clinically relevant effects on the hypothalamic-pituitary-adrenal axis.

This integrated analysis demonstrated that budesonide foam for the induction of remission of distal ulcerative colitis is safe overall, with no clinically relevant effects on the hypothalamic-pituitary-adrenal axis.The gas-phase ammonia (NH3) and fine particle PM2.5 ammonium (pNH4(+)) (collectively, NHx) were monitored between July 2013 and August 2014 in a busy traffic area of Nanjing, China. this website Results showed that PM2.5 concentration was 66.7 μg m(-3), and NH3 concentration was 6.66 μg m(-3). In the PM2.5, the concentration of pNH4(+) was 3.04 μg m(-3), SO4(2-) (pSO4(2-)) was 10.16 μg m(-3), and NO3(-) (pNO3(-)) was 1.60 μg m(-3). The significant correlation curves from the tests of PM2.5 revealed that molar ratio of pNH4(+) and pSO4(2-) was approximately 2, which could be (NH4)2SO4. Particulate NH4(+) primarily associated with pSO4(2-), which accounted for 4.54% of total PM2.5 mass. The PM2.5 observed acidic and the NH3 in the atmosphere neutralized acidic species, mainly in a sulfate form. The traffic intensity in the region was partially related to the formation of PM2.5 and NH3, suggesting that traffic pollution may be an important source of PM2.5. link2 The reaction between NHx and acidic species was assumed to the secondary PM2.5. The neutralization and photochemical property of NHx were discussed.The accumulation of the five trace metals (TMs) cadmium, copper, lead, nickel and zinc was measured in Posidonia oceanica leaves. Shoots were seasonally sampled at 8-10-m depth from four stations located in Port El Kantaoui area, Tunisia, during four campaigns performed in 2012. Levels of the five TMs were analyzed using inductively coupled plasma atomic emission spectrometry (ICP-AES) in three compartments of P. oceanica shoots blades and sheaths of adult leaves and intermediate leaves. Results showed a preferential accumulation of Cd, Pb, Ni and Zn in adult leaf blades. Therefore, we focus on the study of this compartment. TM levels of blades of adult leaves decreased in the following order Zn > Ni > Cu > Pb > Cd, irrespective of the season. Levels of the five TMs significantly differed between seasons (p  less then  0.01). Levels of Cd and Cu showed a seasonal pattern Cd decreased from spring to winter while Cu increased during that same period of time. A significant correlation (p  less then  0.01) was found between Cd-Cu and Cd-Pb. A significant correlation (p  less then  0.05) was also noted between Cd-Ni in the adult leaf blades. A relationship was recorded between the foliar surface of the adult leaf blades and Zn accumulation. This survey allowed to highlight the annual variation of TM accumulation in adult leaf blades of P. oceanica, in relation with ecophysiology of this seagrass. Therefore, this study reinforces the usefulness and the relevance of this compartment of P. oceanica, easy to sample without destruction of whole shoot, as a bioindicator of Zn, Ni, Cd and Pb contamination.

The Argus I implant is the first-generation epiretinal prosthesis approved for an investigational clinical trial by the United States Food and Drug Administration. Herein we report testing results obtained from a 10-year follow-up to study the physiologic effects of the bioelectronic visual implant after prolonged chronic electrical stimulation.

Case report.

One man, 55 years of age when enrolled in the study, underwent surgical implantation of the Argus I in June 2004, followed by periodic tests from July 2004 through June 2014, spanning a total of 10 years.

The decade-long follow-up consisted of implant system performance tests, subject visual function evaluation, and implant-retina interface analysis.

Changes in electrode impedance and perceptual threshold over the time course; subject's performance on visual function task, orientation, and mobility tests; and optical coherence tomography data, fundus imaging, and fluorescein angiography results for the assessment of subject's implant-retina physical interface.

Electrically elicited phosphenes were present 10 years after implantation of an epiretinal stimulator. The test subject not only was able to perceive phosphenes, but also could perform visual tasks at rates well above chance.

This decade-long follow-up report provides further support for the use of retinal prostheses as a long-lasting treatment for some types of blindness.

This decade-long follow-up report provides further support for the use of retinal prostheses as a long-lasting treatment for some types of blindness.

To describe the complications associated with hydrogel explants and to describe the indications, surgical technique, and risks involved in the removal of a hydrogel explant.

Single-center, retrospective interventional case series.

Patients who underwent surgical removal of a symptomatic, swollen hydrogel explant.

We reviewed the medical records of 457 consecutive patients (467 eyes in total) who underwent surgical removal of a symptomatic, swollen episcleral MIRAgel (MIRA Inc., Waltham, MA) explant at the Radboud University Medical Center from 1998 to 2011. link3 We reviewed the initial symptoms, clinical findings, surgical aspects, and intraoperative and postoperative complications.

Presenting symptoms, retinal redetachment rate, and intraoperative scleral perforation.

The median interval between initial placement of the hydrogel explant and removal of the explant was 159 months. More than 34% of the episcleral hydrogel explants developed symptomatic swelling and required surgical removal. Intraoperative scleral perforation or retinal redetachment related to the removal of the explant occurred in 11% of patients.

The percentage of explants that ultimately develop symptomatic swelling is considerably higher than reported previously. A swollen hydrogel explant can be removed many years after the primary detachment surgery, and 11% of cases develop intraoperative scleral perforation or retinal redetachment.

The percentage of explants that ultimately develop symptomatic swelling is considerably higher than reported previously. A swollen hydrogel explant can be removed many years after the primary detachment surgery, and 11% of cases develop intraoperative scleral perforation or retinal redetachment.

To report evolving indications and preferred techniques of corneal transplantation in the United States.

Retrospective review.

Annual reports from the Eye Bank Association of America on corneal graft distribution in the United States from 2005 through 2014 were reviewed.

Number and percentage of corneal grafts distributed for various types of keratoplasty and their surgical indications in the United States.

The total number of corneal transplants increased from 44 277 in 2005 to 46 513 in 2014. In the past decade, penetrating keratoplasty dramatically decreased (from 95% to 42%) and largely has been replaced by various lamellar keratoplasty (LK) techniques (from 5% to 58%). Descemet stripping (automated) endothelial keratoplasty was the most common (50%) type of corneal transplantation performed in the United Stated in 2014. The volume of Descemet membrane endothelial keratoplasty (DMEK) has been doubling every year since 2011 and accounted for 11% of total endothelial keratoplasties in 2014. There was a significant shift in indication for corneal transplantation, with Fuchs' endothelial dystrophy (22%) being the most common, followed by corneal edema occurring after cataract surgery (12%) in 2014. Eye banks supplied precut corneal grafts for 68% of LK techniques in 2014.

In the United States, there has been a major shift in preferred keratoplasty techniques over the past decade, with a wide adoption of new LK techniques.

In the United States, there has been a major shift in preferred keratoplasty techniques over the past decade, with a wide adoption of new LK techniques.